Post on 16-Jan-2016
Dipl. Chem.
Mark Geppert
Center for Biomolecular Interactions, University of Bremen, GermanyCenter for Environmental Research and Sustainable Technology, University of Bremen, Germany
Accumulation of iron oxide nanoparticlesby cultured brain astrocytes
2
Content
• Introduction– Iron oxide nanoparticles– Astrocytes
• Results– Synthesis and characterization of iron oxide nanoparticles– Application of iron oxide nanoparticles to cultured astrocytes
Cell viability
Accumulation of iron
• Summary
3
Iron oxides
• 16 different iron oxides, hydroxides and oxidohydroxides have been described.
• The most important iron oxides are:
– Iron(II)oxide (FeO) Wüstite
– Iron(II,III)oxide (Fe3O4) Magnetite
– Iron(III)oxide (-Fe2O3) Hematite
(-Fe2O3) Maghemite
4
Iron oxide nanoparticles
• Iron oxide nanoparticles consist of an iron oxide core surrounded by a certain a ligand shell.
• The core consists of magnetite (Fe3O4) or maghemite (-Fe2O3).
• The ligands can be small organic molecules, polymers or proteins and are important for the stability of the nanoparticles.
• Iron oxide nanoparticles are superparamagnetic.
Stroh et al. (2004)
5
Applications for iron oxide nanoparticles
• Important potential applications for iron oxide nanoparticles for medicine and neurosciences are:
– Contrast agents in magnetic resonance imaging– Targeted drug delivery– Elimination of tumors by magnetic mediated hyperthermia– Labelling of cells– Magnetic separation of cells
6
Brain cells
PfriePfger & Steinmetz (2003) La Recherche
Neuron
Ependymal Cells
Myelin
Oligodendrocyte
Astrocyte
Synapse
Microglia
Neuron
Capillary
Ventricle
Pfrieger & Steinmetz (2003); modified
7
Astrocytes
• Astrocytes are the most abundant cell type in the brain.
• Astrocytes have a variety of functions in the brain:
– Metabolic support of neurons– Neurotransmitter uptake– Detoxification of xenobiotics– Protection of neurons against oxidative stress– Regulation of metal homeostasis
8
Astrocytes
Immunocytochemical staining of an astroglia-rich primary culuture.
The characteristic marker protein (GFAP) is stained in green, the nuclei were stained with DAPI in blue.
GFAP:glial fibrillary acidic protein
DAPI:4‘,6-Diamidio-2-phenylindole
9
Synthesis of iron oxide nanoparticles
• Iron oxide nanoparticles were synthesized by coprecipitation of ferrous and ferric iron in aqueous media (modified from Bee et al., 1995).
• Further treatment with nitric acid and ferric nitrate leads to a stable aqueous magnetic ferrofluid.
• The yield of the synthesis was
78 ± 10%
Aqueous solution of ferrous and ferric iron
Aqueousammonia solution
Black precipitate(magnetic Fe3O4-particles)
1.) washing with H2O
2.) boiling with HNO3 and Fe(NO3)3
3.) dispersion in H2O
Aqueous dispersion of-Fe2O3-nanoparticles
10
Characterization of iron oxide nanoparticles
Behaviour of an aqueous dispersion of iron oxide nanoparticles (ferrofluid) in a magnetic field.
11
Characterization of iron oxide nanoparticles
TEM images of the synthesized iron oxide nanoparticles
100 nm 20 nm
12
Effects of iron oxide nanoparticles on cultured astrocytes
• Iron oxide nanoparticles were coated with an excess of sodium citrate and dispersed in physiological media.
• The following parameters were investigated after exposure of astrocyte-rich primary cultures to iron oxide nanoparticles:
– Cell viability– Iron accumulation:
1. Time dependency
2. Temperature dependency
3. Effects of iron chelators
13
Cell viability
LDH: lactate dehydrogenase; FAC: ferric ammonium citrate; Fe-NP: iron oxide nanoparticles
time of incubation (h)
6 24
extr
acel
lula
r LD
H a
ctiv
ity(%
of
initi
al L
DH
act
ivity
)
0
20
40
60
80
100
control without iron 100 µM FAC 100 µM Fe-NP1000 µM Fe-NP
***
***
*
14
Iron accumulation
FAC: ferric ammonium citrate; Fe-NP: iron oxide nanoparticles
37 °C
time of incubation (h)0 1 2 3 4 6
cellu
lar
iron
cont
ent
(nm
ol /
mg
prot
ein)
0
100
200
300
100 µM Fe-NP100 µM FACno iron
4 °C
0 1 2 3 4 6
100 µM Fe-NP100 µM FACno iron
15
Temperature dependency
FAC: ferric ammonium citrate; Fe-NP: iron oxide nanoparticles
Col 2 Col 2: -- Col 2: --
iron
accu
mul
atio
n ra
te(n
mol
/ (h
× m
g))
0
10
20
30
40
***
***
FAC Fe-NP
37°C 4°C 37°C 4°C
16
Transmission electron microscopy (TEM)
2 µm 0.5 µm
17
Energy dispersive X-ray spectroscopy (EDX)
TEM
FeFe
18
Perl‘s staining
A
B C
Perl´s stain for iron in astrocyte-rich primary cultures
Fe-NP: iron oxide nanoparticles
no iron 100 µM Fe-NP; 37°C 100 µM Fe-NP; 4°C
19
Effects of iron chelators
FAC: ferric ammonium citrate; Fe-NP: iron oxide nanoparticles
Iron chelators (500 µM): DFX: deferoxamine; FZ: ferrozine
Fe-NP
control DFX FZ
cellu
lar
iron
cont
ent
(nm
ol/m
g pr
otei
n)
0
50
100
150
200
250
300 FAC
control DFX FZ
20
Summary
• Iron oxide nanoparticles (Fe-NP) were synthesized via coprecipitation of ferric and ferrous iron with yields of about 80%.
• Fe-NP were coated with an excess of sodium citrate and dispersed in physiological media for cell culture experiments.
• Fe-NP were less toxic during longer incubation periods than ferric ammonium citrate (FAC), a soluble iron source
• Fe-NP were accumulated by the astrocytes in a time and temperature dependent manner.
• The presence of ferrous or ferric iron chelators did not affect the iron accumulation of Fe-NP.
These results suggest, that astrocytes in culture are able to accumulate iron oxide nanoparticles!
21
Acknowledgements
funding:
Prof. Dr. Ralf Dringen
Dipl. Chem. Michaela Hohnholt
Prof. Dr. Marcus Bäumer Dr. Ingo Grunwald
B. Sc. Linda Gätjen
Thank you for your attention!
Superparamagnetism
• Paramagnets increase their internal magnetization in an external magnetic field
• One can imagine a paramagnetic sample as many magnetic moments (displayed as small bar magnets in pictures)
• They are independent of each other and arrange in an external magnetic field
• If the magnetic field is turned off, they randomize by temperature (≠ferromagnetism)
• Very small particles of ferromagnetic substances (like -Fe2O3) behave paramagnetic with the difference, that every particle consists only of one magnetic moment.
• Magnetism of the particles is important for MRT-imaging.
Quantification of iron content in nanoparticles
• Quantification of the iron content according to the method of Riemer et al. (2004); Anal. Biochem. 331:370-375
• Incubation with „iron releasing reagent“ over night at 60 °C– 0.7-M HCl and 2.25% KMnO4
• Reduction of iron with ascorbate and detection of ferrous iron with ferrozine (magenta-coloured complex)
X-Ray diffraction
Dynamic light scattering
Intensity weighted diameter distribution
Diameter (nm)
A(I)
1 10 100 10000.00
0.01
0.02
0.03
0.04
0.05
10 mM Fe-NP in water: Mean diameter = 38 nm10 mM Fe-NP + 100 mM Citrat: Mean diameter = 40 nm
TEM
Concentration dependency